Novo Nordisk, Eli Lilly rake in cash from weight-loss drugs - The Washington Post
washingtonpost.comSubmitted by thewashingtonpost7104 in business
Novo Nordisk and Eli Lilly reported booming sales from their blockbuster diabetes and weight-loss drugs as both race to keep up with consumer demand.